Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Krsnaa Diagnostics Limited ( (IN:KRSNAA) ) has provided an update.
Krsnaa Diagnostics Limited reported its highest-ever quarterly profit, with a 12% year-on-year revenue growth in H1 FY26, driven by expanding patient volumes and confidence in its diagnostic network. The company’s EBITDA increased by 18% year-on-year, reflecting strong operating leverage and disciplined execution. The Rajasthan rollout is expected to unlock future growth potential, further strengthening Krsnaa’s market position. The company’s focus on profitable and sustainable growth is underscored by a 19% rise in net profit, and its strategic partnerships with government entities ensure quality receivables and credibility.
More about Krsnaa Diagnostics Limited
Krsnaa Diagnostics Ltd. is one of India’s fastest-growing integrated diagnostic service providers, known for its efficient and inclusive diagnostic platforms. The company operates across Tier-II and Tier-III markets through a Public-Private Partnership model, which supports volume growth and provides stability through long-term contracts and geographic diversification.
Average Trading Volume: 8,025
Technical Sentiment Signal: Buy
Current Market Cap: 24.96B INR
For detailed information about KRSNAA stock, go to TipRanks’ Stock Analysis page.